Meditrina Pharmaceuticals develops and offers pharmaceutical products including food supplements and medical devices, self-described as focused on a comprehensive organization for the future.

Meditrina Pharmaceuticals

IPhone / Mobile Compatible

Viewport Meta

Amazon

Global Site Tag

AdBlock Acceptable Ads

Google Adsense for Domains

Outbrain Pixel

Bodis DNS

Jack Luderer

Acting Chief Medical Officer

Health Care Early Stage Companies With Less Than $50M in Revenue

Great Lakes Startups

United States Therapeutics Companies (Top 10K)

United States Health Care Companies with Early Stage Venture Funding

Meditrina Pharmaceuticals, Inc. identifies and repurposes already marketed therapies and product candidates at advanced stages of development for new indications focused on improving women’s health disorders with unmet medical needs.  The Company’s initial focus is in overlooked therapeutic areas that affect millions of women each year.  These areas include gynecologic and aromatase-meditated conditions such as endometriosis and uterine fibroids.

Debt Financing - Meditrina Pharmaceuticals, Inc

Series A - Meditrina Pharmaceuticals, Inc

Ann Arbor

Michigan

United States

North America

Meditrina Pharmaceuticals, Inc

HTML5

Bodis

F5 NGINX

Google Tag Manager

jQuery

Cloudflare CDN

Bootstrap

Google Analytics

Google Fonts

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Nov 20, 2024 11:45 AM	b044673a
public peers	general	Sep 30, 2024 1:24 PM	ac67b9af
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 30, 2024 1:24 PM	5aebc6b7
crunchbase trigger	general	Oct 28, 2024 1:51 PM	e612dad1
crunchbase profile	general	Oct 29, 2024 10:00 AM	9a18e1a3
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	a729469f
peers	general	Sep 30, 2024 1:24 PM	ba1b6601
news basic	general	Sep 30, 2024 1:24 PM	ec0d100d
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

GR:MEDITRINA

Meditrina Pharmaceuticals